Skip to main content
Fig. 1 | Genome Medicine

Fig. 1

From: Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations

Fig. 1

Degree of copy number aberrations between different response groups within each treatment arm. a Difference in genomic instability index (GII, y-axis) between patients obtaining pCR and non-pCR (x-axis). No significant difference was observed in either treatment arm (Student’s t test). b Significant difference in tumors’ GII between patients with good response (GR), intermediate response (IR), and no response (NR) (ANOVA test p value < 0.05) within both treatment arms

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us